Linked inTwitter

Halcyon actively monitors change covering more than 150 key elements of life.

The 52:52:52 project, launching both on this site and on Twitter at the beginning of 2023 will help you address 52 issues with 52 responses over 52 weeks.

A Mundane Comedy will be Dominic Kelleher's new book, published in early 2023. Extracts will appear on this site and on my social media accounts the final quarter of 2022. Please get in touch with any questions or thoughts.

Genes

On CRISPR

Genetics

 

40%: The percentage of patients reported to have responded to one of the most advanced CRISPR cancer therapy studies to be tested in China. China is far ahead of the US in CRISPR cancer studies due to its less stringent approval requirements, but the US and Europe are set to see their first human trials of the gene-editing technique this year. With potentially transformative implications across medicine, agriculture, and even chemical products, CB Insights' 5,200-word CRISPR deep dive unpacks the science behind the technology, its applications, controversies it’s stirred up, and where CRISPR may take us next.